Ksenia Sokolova

Dr. Ksenia Sokolova

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FAFeyisayo Olabisi Adepoju
Feyisayo Olabisi Adepoju
KSKsenia Sokolova
Ksenia Sokolova
IGIrina F. Gette
Irina F. Gette
IDIrina G. Danilova
Irina G. Danilova
Mikhail TsurkanMikhail Tsurkan
Mikhail Tsurkan
Jose MirandaJose Miranda
Jose Miranda
Type 2 diabetes is characterized by hyperglycemia and a relative loss of β–cell function. Our research investigated the antidiabetic potential of betulin, a pentacyclic triterpenoid found primarily in birch bark and, intriguingly, in a few marine organisms. Betulin has been shown to possess diverse biological activities, including antioxidant and antidiabetic activities; however, no studies have fully explored the effects of betulin on the pancreas and pancreatic islets. In this study, we investigated the effect of betulin on streptozotocin–nicotinamide (STZ)-induced diabetes in female Wistar rats. Betulin was prepared as an emulsion, and intragastric treatments were administered at doses of 20 and 50 mg/kg for 28 days. The effect of treatment was assessed by analyzing glucose parameters such as fasting blood glucose, hemoglobin A1C, and glucose tolerance; hepatic and renal biomarkers; lipid peroxidation; antioxidant enzymes; immunohistochemical analysis; and hematological indices. Administration of betulin improved the glycemic response and decreased α–amylase activity in diabetic rats, although insulin levels and homeostatic model assessment for insulin resistance (HOMA–IR) scores remained unchanged. Furthermore, betulin lowered the levels of hepatic biomarkers (aspartate aminotransferase, alanine aminotransferase, and alpha-amylase activities) and renal biomarkers (urea and creatine), in addition to improving glutathione levels and preventing the elevation of lipid peroxidation in diabetic animals. We also found that betulin promoted the regeneration of β–cells in a dose-dependent manner but did not have toxic effects on the pancreas. In conclusion, betulin at a dose of 50 mg/kg exerts a pronounced protective effect against cytolysis, diabetic nephropathy, and damage to the acinar pancreas and may be a potential treatment option for diabetes.

Verified
Journal Article
Open access
PDF file
MAMusa T. Abidov
Musa T. Abidov
KSKsenia Sokolova
Ksenia Sokolova
IGIrina F. Gette
Irina F. Gette
IDIrina G. Danilova
Irina G. Danilova
β-cells dysfunction plays an important role in the pathogenesis of type 2 diabetes (T2D), partially may be compensated by the generation of extra-islet insulin-producing cells (IPCs) in pancreatic acini and ducts. Pdx1 expression and inflammatory level are suggested to be involved in the generation of extra-islet IPCs, but the exact reasons and mechanisms of it are unclear. Macrophages are key inflammatory mediators in T2D. We studied changes in mass and characteristics of extra-islet IPCs in rats with a streptozotocin-nicotinamide model of T2D and after i.m. administration of 20 daily doses of 2 mg/kg b.w. sodium aminophthalhydrazide (APH). Previously, we found that APH modulates macrophage production and increases the proliferative activity of pancreatic β-cells. Expressions of insulin and Pdx1, as well as F4/80 (macrophage marker), were detected at the protein level by immunohistochemistry analysis, the concentration of pro- and anti-inflammatory cytokines in blood and pancreas—by ELISA. Diabetic rats treated with APH showed an increasing mass of extra-islet IPCs and the content of insulin in them. The presence of Pdx1+ cells in the exocrine pancreas also increased. F4/80+ cell reduction was accompanied by increasing TGF-β1 content. Interestingly, during the development of diabetes, the mass of β-cells decreased faster than the mass of extra-islet IPCs, and extra-islet IPCs reacted to experimental T2D differently depending on their acinar or ductal location.

29 May 2023 in Foods and Raw Materials
Verified
Journal Article
Open access
STSergei Tikhonov
Sergei Tikhonov
NTNatalia Tikhonova
Natalia Tikhonova
IGIrina Gette
Irina Gette
KSKsenia Sokolova
Ksenia Sokolova
IDIrina Danilova
Irina Danilova
Peptides of plant and animal origin have good anti-diabetic prospects. The research objective was to use bovine colostrum peptides to reduce hyperglycemia in diabetic rats. Bovine colostrum peptides were obtained by trypsin hydrolysis of colostrum proteins with preliminary extraction of triglycerides. The study involved four groups of Wistar rats with seven animals per group. Group 1 served as control; group 2 received 300 mg/kg of trypsin hydrolysate of bovine colostrum as part of their daily diet for 30 days. Groups 3 and 4 had diabetes mellitus caused by intraperitoneal injections of 110 mg/kg of nicotinamide and 65 mg/kg of streptozotocin. Group 4 also received 300 mg/kg trypsin hydrolysate of bovine colostrum intragastrically five times a week for 30 days. Three peptides were isolated from the trypsin hydrolysate of bovine colostrum and tested for the sequence of amino acids and molecular weight. Their identification involved the Protein NCBI database, followed by 2D and 3D modeling, which revealed their chemical profile, pharmacological properties, and antioxidant activity. The diabetic rats treated with colostrum peptides had lower glucose, glycated hemoglobin, malondialdehyde, and catalase activity but a higher content of glutathione in the blood. Their leukocytes and erythrocytes also demonstrated less deviation from the standard. The antioxidant effect of colostrum protein hydrolysate depended on a peptide with the amino acid sequence of SQKKKNCPNGTRIRVPGPGP and a mass of 8.4 kDa. Colostrum peptides reduced hyperglycemia and oxidative stress in diabetic rats. The research revealed good prospects for isolating individual colostrum peptides to be tested for antidiabetic properties.

7 January 2021 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
MBM. B. Baykenova
M. B. Baykenova
VCV. A. Chereshnev
V. A. Chereshnev
KSKsenia Sokolova
Ksenia Sokolova
IGI. F. Gette
I. F. Gette
VEV. V. Emelianov
V. V. Emelianov
IDI. G. Danilova
I. G. Danilova
Инсулин-позитивные клетки печени и экзокринной части поджелудочной железы у животных с экспериментальным сахарным диабетом

23 December 2023 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
KSKsenia Sokolova
Ksenia Sokolova
IDI. G. Danilova
I. G. Danilova
   Introduction. View about hepatic macrophages as key regulators of tissue homeostasis, acting via innate and adaptive immune reactions, stimulated by exogenous and/or endogenous alarm signals of tissue injury or cell stress is substantiated in the review. From one hand, environmental signals determine macrophage polarization and production, but, on the other hand, macrophages affect tissue microenvironment and cells and tissue function at whole. The review was aimed to provide recent evidence of macrophage role in maintenance of tissue homeostasis in liver.   Materials and Methods. Review is based on the 67 scientific articles, devoted to the study and analysis of macrophage role in the maintenance of tissue homeostasis in liver, found in PubMed database. Most of the analyzed articles (40 from 67) were published in 2017-2023.   Results and Discussion. Information of origin and morpho-functional heterogeneity of hepatic macrophages was summarized in the review.   Conclusion. The information presented in the review allow to conclude that macrophages are key regulators of homeostasis in the liver due to their ability to perceive many endogenous and exogenous signals in tissues and quickly respond to them in the direction of stabilizing the tissue microenvironment.

19 April 2026 in Actual problems in dentistry
Verified
Journal Article
Open access
PDF file
IAIrina Alekseeva
Irina Alekseeva
LKLarisa Kisel'NIkova
Larisa Kisel'NIkova
VAVasilii Aliamovskii
Vasilii Aliamovskii
APAleksandra Pershina
Aleksandra Pershina
IDIrina Danilova
Irina Danilova
AVAnastasia Vartomyants-Chupryakova
Anastasia Vartomyants-Chupryakova
Background. Osteogenesis imperfecta (OI) is a hereditary connective tissue disorder affecting skeletal and dental tissues. The aim: to assess the dental status and content of vitamin D, osteocalcin, osteoprotegerin, bone alkaline phosphatase, and parathyroid hormone in mixed saliva, and to study the relationship between clinical and laboratory parameters and bone tissue status in children with osteogenesis imperfecta. Materials and Methods: A study was conducted at the Department of Pediatric Dentistry "CS and Maxillofacial Surgery" of the A.I. Evdokimov Scientific Research Institute of Dentistry. The study involved 20 apparently healthy children (health groups 1 and 2) aged 8–17 years (average age 12 years) seeking dental care (comparison group) and 26 children of the same age with a genetically diagnosed condition, osteogenesis imperfecta (study group), referred from the GMSClinic in Moscow. The study was approved by the Ethics Committee of the Russian University of Medicine (Extract from Protocol No. 02-24 of the Interuniversity Ethics Committee dated February 15, 2024). The study consisted of clinical and biochemical phases. The dental status was assessed using standard dental indices. The content of mineralization markers in mixed saliva was determined using enzyme-linked immunosorbent assay (ELISA). Results: Compared with healthy children, children with osteogenesis imperfecta had higher dental status indicators associated with a deficiency of vitamin D and bone metabolism regulatory factors (ABP, OST, TFR), possibly indicating impaired mineralization of the skeleton, dental tissues, and periodontium in children with this pathology. From a clinical point of view, the established relationships between the studied clinical and laboratory parameters determine the need to classify children with imperfect osteogenesis as a high-risk group for dental problems.